ai powered software solution Search Results


90
SimBioSys Inc ai-powered visualization software platform
Ai Powered Visualization Software Platform, supplied by SimBioSys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/pmc11564706__41523_2024_696_MOESM1_ESM-0-9-63?v=SimBioSys+Inc
Average 90 stars, based on 1 article reviews
ai-powered visualization software platform - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Monsoon Solutions Inc power tool software
Power Tool Software, supplied by Monsoon Solutions Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/pm27392646-233-11-15?v=Monsoon+Solutions+Inc
Average 90 stars, based on 1 article reviews
power tool software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Abbott Laboratories ai powered ivoct plaque characterization software
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Ivoct Plaque Characterization Software, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/pmc12341395-373-5-14?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
ai powered ivoct plaque characterization software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Visiopharm AS ai-powered image analysis software platform
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Image Analysis Software Platform, supplied by Visiopharm AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/pm40407141-132-8-7?v=Visiopharm+AS
Average 90 stars, based on 1 article reviews
ai-powered image analysis software platform - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Sutro Biopharma ai-powered software development testing platform
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Software Development Testing Platform, supplied by Sutro Biopharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/10__47363_slash_jaicc_slash_2024_ascii40_3_ascii41_397-74-50-44?v=Sutro+Biopharma
Average 90 stars, based on 1 article reviews
ai-powered software development testing platform - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Cleerly Inc ai powered software solution
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Software Solution, supplied by Cleerly Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/10__1016_slash_j__ajpc__2026__101462-50-1-4?v=Cleerly+Inc
Average 86 stars, based on 1 article reviews
ai powered software solution - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Volpara Solutions Ltd intelligence ai evaluation software
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Intelligence Ai Evaluation Software, supplied by Volpara Solutions Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/pm42085898-47-6-10?v=Volpara+Solutions+Ltd
Average 86 stars, based on 1 article reviews
intelligence ai evaluation software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Philips Healthcare ai powered software
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Software, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/10__1016_slash_j__echo__2025__06__013-5199-19-23?v=Philips+Healthcare
Average 86 stars, based on 1 article reviews
ai powered software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
On Demand Pharmaceuticals ai powered assessment software
Diagram illustrating the computational analysis of <t>IVOCT</t> for future clinical support.
Ai Powered Assessment Software, supplied by On Demand Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ai+powered+software+solution/10__37547_slash_tajmspr_slash_volume07issue03___15-256-5-10?v=On+Demand+Pharmaceuticals
Average 86 stars, based on 1 article reviews
ai powered assessment software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Diagram illustrating the computational analysis of IVOCT for future clinical support.

Journal: IEEE reviews in biomedical engineering

Article Title: Computational Analysis of Intravascular OCT Images for Future Clinical Support: A Comprehensive Review

doi: 10.1109/RBME.2025.3530244

Figure Lengend Snippet: Diagram illustrating the computational analysis of IVOCT for future clinical support.

Article Snippet: The recent FDA approval of AI-powered IVOCT plaque characterization software (e.g., Ultreon TM 2.0, Abbott Vascular, Santa Clara, CA, USA) marks a significant advancement, with its clinical use underway.

Techniques:

Successful pixel-wise classification examples from certain datasets. column-(a) IVOCT image, column-(b) ground-truth, and column-(c) illustrates the segmentation results obtained with our proposed deep learning neural network. The annotation colors for each tissue is denoted at the bottom of the resulting plane.

Journal: IEEE reviews in biomedical engineering

Article Title: Computational Analysis of Intravascular OCT Images for Future Clinical Support: A Comprehensive Review

doi: 10.1109/RBME.2025.3530244

Figure Lengend Snippet: Successful pixel-wise classification examples from certain datasets. column-(a) IVOCT image, column-(b) ground-truth, and column-(c) illustrates the segmentation results obtained with our proposed deep learning neural network. The annotation colors for each tissue is denoted at the bottom of the resulting plane.

Article Snippet: The recent FDA approval of AI-powered IVOCT plaque characterization software (e.g., Ultreon TM 2.0, Abbott Vascular, Santa Clara, CA, USA) marks a significant advancement, with its clinical use underway.

Techniques:

Three-dimensional (3D) visualizations of fibrous cap thickness on the representative IVOCT pullbacks, including: (a) short lesion with TCFA, (b) long lesion with TCFA, (c) short lesion without TCFA, and (d) long lesion without TCFA. The reader can zoom in each artery to see variations of fibrous cap thickness. (a) Although the lesion length was not too long (< 7 mm), the average fibrous cap thickness was less than 65 μ m across the lesion indicating that the lesion is prone to rupture. (b) There were two lipidous lesions having 15 mm (left) and 5 mm (right) lengths. Both lesions were heavily lipidic with a mean cap thickness of < 65 μ m. The artery was much more prone to rupture than (a). (c) The lesion was stable, since the length was short (< 3 mm) and the fibrous cap thickness was always greater than 150 μ m. (d) Although the fibrous cap thickness was always over 80 μ m across the lesion, the lesion length was very long (> 30 mm). There were several spots approaching toward the vulnerable plaque than (c). The color map visualizes the fibrous cap in the range of 0 to 300 μ m. The yellow arrows indicate representative IVOCT frames of each rendering. Our method provides comprehensive fibrous cap map in the entire IVOCT pullback, so clinicians can make appropriate treatment decisions.

Journal: IEEE reviews in biomedical engineering

Article Title: Computational Analysis of Intravascular OCT Images for Future Clinical Support: A Comprehensive Review

doi: 10.1109/RBME.2025.3530244

Figure Lengend Snippet: Three-dimensional (3D) visualizations of fibrous cap thickness on the representative IVOCT pullbacks, including: (a) short lesion with TCFA, (b) long lesion with TCFA, (c) short lesion without TCFA, and (d) long lesion without TCFA. The reader can zoom in each artery to see variations of fibrous cap thickness. (a) Although the lesion length was not too long (< 7 mm), the average fibrous cap thickness was less than 65 μ m across the lesion indicating that the lesion is prone to rupture. (b) There were two lipidous lesions having 15 mm (left) and 5 mm (right) lengths. Both lesions were heavily lipidic with a mean cap thickness of < 65 μ m. The artery was much more prone to rupture than (a). (c) The lesion was stable, since the length was short (< 3 mm) and the fibrous cap thickness was always greater than 150 μ m. (d) Although the fibrous cap thickness was always over 80 μ m across the lesion, the lesion length was very long (> 30 mm). There were several spots approaching toward the vulnerable plaque than (c). The color map visualizes the fibrous cap in the range of 0 to 300 μ m. The yellow arrows indicate representative IVOCT frames of each rendering. Our method provides comprehensive fibrous cap map in the entire IVOCT pullback, so clinicians can make appropriate treatment decisions.

Article Snippet: The recent FDA approval of AI-powered IVOCT plaque characterization software (e.g., Ultreon TM 2.0, Abbott Vascular, Santa Clara, CA, USA) marks a significant advancement, with its clinical use underway.

Techniques: